Finally, poor response to immunotherapy was initially reported and suggested a primary neurodegenerative aetiology of IgLON5-IgG disease [1,31]; however, more recent evidence is discordant with this [2,8,32]. Here, IGLON5 is linked to glycogen storage disease VI.